Erwin De Genst - Concepedia

Author

Erwin De Genst

University of Cambridge ORCID

Also Known As

De Genst, Erwin, E. De Genst, E.D. Genst, Erwin De Genst, Erwin De Genst, Erwin de Genst, Genst, Erwin De

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

University of Cambridge Vrije Universiteit Brussel Vlaams Instituut voor Biotechnologie Neural Stem Cell Institute University College London

About

Erwin De Genst is an author at University of Cambridge specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Natural Sciences	7	7	374
3	Engineering	3	3	166
4	Social Sciences	1	1	11
5	Applied Physics	1	1	110

Erwin De Genst

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies Erwin De Genst, Karen Silence, Klaas Decanniere, Proceedings of the National Academy of Sciences	2006	653
Camelid immunoglobulins and nanobody technology Serge Muyldermans, Toya Nath Baral, V. Cortez Retamozzo, Veterinary Immunology and Immunopathology VaccinationVeterinary VaccineImmunoengineeringImmunologyImmunochemistry	2008	522
Receptor binding studies disclose a novel class of high‐affinity inhibitors of the <i>Escherichia coli</i> FimH adhesin Julie Bouckaert, Jenny Berglund, Mark A. Schembri, Molecular Microbiology	2004	435
Molecular Basis of Gyrase Poisoning by the Addiction Toxin CcdB Minh‐Hoa Dao‐Thi, Laurence Van Melderen, Erwin De Genst, Journal of Molecular Biology BiochemistryAddictionMedicineMechanism Of ActionPoisoning	2005	144
Silk micrococoons for protein stabilisation and molecular encapsulation Ulyana Shimanovich, Francesco Simone Ruggeri, Erwin De Genst, Nature Communications	2017	131
Wnt3a binds to several sFRPs in the nanomolar range Danuta Wawrzak, Mourad Métioui, Erik Willems, Biochemical and Biophysical Research Communications Nanoscale ScienceNanoscale SystemEngineeringNanotechnologyApplied Physics	2007	110
Nanobodies Raised against Monomeric α-Synuclein Distinguish between Fibrils at Different Maturation Stages Tim Guilliams, Farah El-Turk, Alexander K. Buell, Journal of Molecular Biology	2013	106
Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate Thomas R. Transue, Erwin De Genst, Mehdi Arbabi Ghahroudi, Proteins Structure Function and Bioinformatics	1998	102
Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model Diptaman Chatterjee, Mansi A. Bhatt, David Butler, npj Parkinson s Disease	2018	97
The fimbrial adhesin F17‐G of enterotoxigenic <i>Escherichia coli</i> has an immunoglobulin‐like lectin domain that binds <i>N</i>‐acetylglucosamine L. Buts, Julie Bouckaert, Erwin De Genst, Molecular Microbiology Microbial PathogensF17-g BindingImmunologyGlycobiologyMolecular Biology	2003	95

Page 1